GO:0004483 methyltransferase cap1 activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004483 (methyltransferase cap1 activity) catalyzes the S-adenosyl-L-methionine-dependent 2'-O-methylation of the first transcribed nucleotide of mRNA and snRNA, converting the cap0 structure into cap1.
• The reaction consumes SAM and releases S-adenosyl-L-homocysteine and H+, and it acts on the N7-methyl 5'-triphosphoguanosine cap already installed by the guanine-N7 methyltransferase.
• In humans, CMTr1 is the principal cap1 methyltransferase, and it cooperates with the RNA helicase DHX15 to modify RNAs with highly structured 5' termini.
• Cap-proximal ribose methylation is essential for mammalian embryonic development and fertility, and loss of cap1 causes early embryonic lethality in mice.
• Viruses encode their own cap1 2'-O-methyltransferases, including chikungunya virus nsP1 and African swine fever virus EP424R, making this activity a validated antiviral target.
• Cap1 methylation can be studied with structural biology, kinetic assays, bisubstrate inhibitors, RNA-seq, and CRISPR-engineered cell models.
Description
GO:0004483, methyltransferase cap1 activity, is a molecular_function term describing the catalysis of a 5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside in mRNA or snRNA plus S-adenosyl-L-methionine to a 5'-end (N(7)-methyl 5'-triphosphoguanosine)-(2'-O-methyl-ribonucleoside) in mRNA or snRNA plus S-adenosyl-L-homocysteine plus H+. In other words, it is the enzyme activity that adds a methyl group to the 2'-O position of the first transcribed nucleotide of an RNA that already carries an N7-methylguanosine cap, converting cap0 into cap1. This modification is a conserved feature of eukaryotic mRNA and snRNA and is installed co-transcriptionally in human cells. Researchers study GO:0004483 because it controls RNA stability, translation, and innate immune recognition, and because its dysregulation is linked to developmental failure and viral pathogenesis.
methyltransferase cap1 activity At A Glance
| GO ID | GO:0004483 |
|---|---|
| GO term | methyltransferase cap1 activity |
| Ontology | molecular_function |
| Synonym | mRNA (nucleoside-2'-O-)-methyltransferase activity; messenger ribonucleate nucleoside 2'-methyltransferase activity; S-adenosyl-L-methionine:mRNA (nucleoside-2'-O-)-methyltransferase activity |
| Major function | 2'-O-methylation of the first transcribed nucleotide of mRNA and snRNA to convert cap0 to cap1 |
| Substrate | 5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside in mRNA or snRNA |
| Cofactor | S-adenosyl-L-methionine (SAM) |
| Products | cap1 RNA, S-adenosyl-L-homocysteine, H+ |
| Cellular context | Co-transcriptional RNA capping in the nucleus, with links to RNA helicase DHX15 for structured 5' termini |
What Is GO:0004483?
Methyltransferase cap1 activity (GO:0004483) is the enzymatic activity that methylates the ribose of the first transcribed nucleotide of mRNA or snRNA at the 2'-O position, using S-adenosyl-L-methionine as the methyl donor. The substrate is an RNA whose 5' end already carries an N7-methyl 5'-triphosphoguanosine cap (cap0), and the product is the corresponding 2'-O-methylated cap1 structure. The reaction releases S-adenosyl-L-homocysteine and a proton. This activity is distinct from guanine-N7 methyltransferase activity, which creates the cap0 structure, and it acts on the cap-proximal nucleotide rather than the guanosine cap itself.
Why Is methyltransferase cap1 activity Important in Cell Biology?
Methyltransferase cap1 activity matters because the cap1 structure is a fundamental determinant of eukaryotic RNA fate and a key interface between host and pathogen. In mammals, cap-proximal ribose methylation is required for embryonic development and fertility, and its loss causes early embryonic lethality. In viruses, dedicated cap1 2'-O-methyltransferases such as chikungunya virus nsP1 and African swine fever virus EP424R are essential for replication and for evasion of innate immune sensing, making GO:0004483 a target for antiviral drug discovery.
• Cap1 methylation is required for normal mammalian embryonic development and fertility.
• Loss of cap1 2'-O-methylation causes early embryonic lethality in mice.
• Cap1 is a molecular signature that helps the cell distinguish self RNA from foreign RNA.
• Viral cap1 methyltransferases, such as chikungunya nsP1 and ASFV EP424R, are essential for viral replication.
• Bisubstrate inhibitors targeting viral cap 2'-O-methyltransferases are being developed as antivirals.
• Human CMTr1 cooperates with DHX15 to modify RNAs with structured 5' ends, linking cap1 to RNA helicase function.
• Drosophila cap1 2'-O-ribose methyltransferase functions in the small RNA silencing pathway associated with Argonaute 2.
• Structural studies of human co-transcriptional capping reveal how cap1 methylation is coordinated with transcription.
• Kinetic characterization of human mRNA guanine-N7 methyltransferase provides a framework for understanding the preceding cap0 step.
• CRISPR-engineered cell models enable causal testing of cap1 methyltransferase genes in disease and infection.
Molecular Mechanism of methyltransferase cap1 activity
Substrate recognition and cap0 binding
In simple terms: The enzyme first grabs an RNA that already has a basic cap, called cap0, and positions the first nucleotide in its active site.
Methyltransferase cap1 activity acts on mRNA or snRNA carrying an N7-methyl 5'-triphosphoguanosine cap, the cap0 structure. Structural analysis of human co-transcriptional capping shows how the capping machinery recognizes the 5' end of the nascent transcript and positions the cap-proximal nucleotide for subsequent 2'-O-methylation. Human CMTr1, the principal cap1 methyltransferase, cooperates with the RNA helicase DHX15 to modify RNAs with highly structured 5' termini, indicating that substrate accessibility is an important determinant of activity.
SAM-dependent methyl transfer
In simple terms: The enzyme uses SAM as a methyl donor and transfers the methyl group onto the 2'-O position of the first RNA nucleotide.
The catalytic reaction uses S-adenosyl-L-methionine as the methyl donor and converts the cap0 substrate into a cap1 product, releasing S-adenosyl-L-homocysteine and H+. This chemistry is shared with other RNA cap methyltransferases, including the human mRNA guanine-N7 methyltransferase that installs the preceding cap0 modification. Kinetic characterization of human guanine-N7 methyltransferase provides a quantitative framework for understanding the ordered methyl transfer steps in cap formation.
Co-transcriptional coordination
In simple terms: Cap1 methylation happens while the RNA is still being made, tightly coordinated with transcription and the earlier capping steps.
Human co-transcriptional capping studies reveal that cap1 methylation is coordinated with transcription and with the enzymes that build the cap0 structure. This coordination ensures that the 5' end of the transcript is modified before the RNA is exported or translated. The cooperation between CMTr1 and DHX15 further suggests that RNA structure at the 5' terminus influences whether cap1 methylation occurs efficiently.
Viral and non-human cap1 methyltransferases
In simple terms: Viruses and insects have their own versions of this enzyme, which perform the same chemical reaction but in different biological contexts.
Chikungunya virus nonstructural protein 1 is a versatile RNA capping and decapping enzyme, and African swine fever virus EP424R functions as a 2'-O-methyltransferase important for viral replication. Drosophila cap1 2'-O-ribose methyltransferase acts in the small RNA silencing pathway associated with Argonaute 2, showing that GO:0004483-related activity is conserved beyond mammals. These non-human enzymes provide tractable models for studying the mechanism and inhibition of cap1 methylation.
Inhibition by bisubstrate analogues
In simple terms: Chemists have designed molecules that mimic both the RNA cap and SAM at once, allowing them to block the enzyme.
5'-cap RNA/SAM mimetic conjugates act as bisubstrate inhibitors of viral RNA cap 2'-O-methyltransferases, demonstrating that the dual substrate-binding mode of GO:0004483 can be exploited pharmacologically. Such inhibitors are valuable tools for probing the function of cap1 methylation in cells and for antiviral development. Structural and kinetic studies of human and viral cap methyltransferases support rational design of these inhibitors.
Key Genes Involved in GO:0004483 methyltransferase cap1 activity
The following genes and proteins are experimentally linked to methyltransferase cap1 activity (GO:0004483) and its regulation in human, viral, and model-organism systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CMTr1 | Human cap1 2'-O-ribose methyltransferase that converts cap0 to cap1 | Core enzyme for studying GO:0004483; cooperates with DHX15 on structured 5' termini |
| DHX15 | RNA helicase that cooperates with CMTr1 to modify RNAs with highly structured 5' termini | Modifier of cap1 methylation efficiency on structured RNAs |
| RNMT | Human mRNA guanine-N7 methyltransferase that installs the cap0 structure preceding cap1 | Upstream enzyme providing the substrate for cap1 methylation |
| RNGTT | Human RNA guanylyltransferase that adds the G cap to the 5' end | Part of the co-transcriptional capping machinery that feeds into cap1 |
| nsP1 | Chikungunya virus nonstructural protein 1 with RNA capping and decapping activities | Viral model for cap1-related chemistry and antiviral targeting |
| EP424R | African swine fever virus 2'-O-methyltransferase important for viral replication | Viral cap1 methyltransferase and antiviral target |
| Ago2 | Argonaute 2, associated with the small RNA silencing pathway involving Drosophila cap1 methyltransferase | Links cap1 methylation to small RNA silencing |
| Drosophila cap1 MTase | Drosophila cap1 2'-O-ribose methyltransferase | Invertebrate model for cap1 function in RNA silencing |
| SAM | S-adenosyl-L-methionine, the methyl donor for the reaction | Cofactor required for cap1 methyltransferase activity |
| SAH | S-adenosyl-L-homocysteine, a product and feedback inhibitor | Product of the reaction; relevant to assay design |
| Cap0 RNA | Substrate with N7-methyl 5'-triphosphoguanosine cap | Substrate for cap1 methyltransferase assays |
| Cap1 RNA | Product with 2'-O-methylated first transcribed nucleotide | Readout for cap1 methyltransferase activity |
| Mammalian embryo model | Genetic system showing requirement for cap-proximal ribose methylation | Demonstrates essential role of cap1 in development and fertility |
| Bisubstrate inhibitor scaffold | Synthetic cap RNA/SAM mimetic conjugate | Chemical probe and antiviral lead targeting cap 2'-O-methyltransferases |
| CMTr1-DHX15 complex | Functional partnership for structured RNA modification | Model for studying substrate selectivity of cap1 methylation |
| Viral 2'-O-MTase | Viral enzymes with cap1 methyltransferase activity | Target for antiviral drug discovery |
How Is methyltransferase cap1 activity Regulated?
Methyltransferase cap1 activity is regulated at multiple levels. Substrate accessibility is influenced by RNA structure, and human CMTr1 cooperates with the RNA helicase DHX15 to modify RNAs with highly structured 5' termini. The reaction is chemically coupled to the availability of S-adenosyl-L-methionine and is inhibited by its product S-adenosyl-L-homocysteine. Co-transcriptional coordination with the cap0-forming machinery ensures that cap1 methylation occurs on nascent transcripts. In viruses, cap1 methyltransferase activity is encoded by dedicated viral proteins such as chikungunya nsP1 and ASFV EP424R, whose expression is tied to the viral replication cycle.
methyltransferase cap1 activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CMTr1 | Embryonic development and fertility defects | CMTr1 knockout and point-mutation cell lines and mouse models |
| DHX15 | Structured RNA modification and cap1 efficiency | DHX15 knockout cells with RNA-seq and cap1 assays |
| nsP1 | Chikungunya virus replication | Viral replicon systems and nsP1 mutant viruses |
| EP424R | African swine fever virus replication | EP424R mutant virus and overexpression cell models |
| Viral 2'-O-MTase | Antiviral drug discovery | Bisubstrate inhibitor testing in infected cells |
Developmental failure and infertility
Cap-proximal ribose methylation is essential for mammalian embryonic development and fertility, and disruption of this modification causes early embryonic lethality in mice. This establishes GO:0004483 as a critical activity for normal development and reproductive biology.
Viral pathogenesis
Viruses rely on cap1 2'-O-methyltransferases for replication and immune evasion. Chikungunya virus nsP1 is a versatile capping and decapping enzyme, and African swine fever virus EP424R functions as a 2'-O-methyltransferase important for viral replication. Inhibiting these viral enzymes with bisubstrate analogues is a promising antiviral strategy.
RNA silencing and gene regulation
In Drosophila, cap1 2'-O-ribose methyltransferase functions in the small RNA silencing pathway associated with Argonaute 2, linking GO:0004483 to post-transcriptional gene regulation. This connection suggests that cap1 methylation can influence small RNA biology beyond its canonical role in mRNA stability and translation.
From methyltransferase cap1 activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is CMTr1 required for cap1 methylation and cell viability? | CMTr1 knockout cell line |
| Does a catalytic point mutation abolish cap1 methyltransferase activity? | CMTr1 catalytic-dead point-mutation knock-in |
| How does DHX15 affect cap1 modification of structured RNAs? | DHX15 knockout or tagged knock-in with RNA-seq |
| Can viral cap1 methyltransferase be inhibited? | Viral enzyme overexpression and bisubstrate inhibitor treatment |
| What is the developmental consequence of losing cap1? | Mammalian embryo model with cap1 pathway disruption |
| How does cap1 methylation affect small RNA silencing? | Drosophila cap1 methyltransferase mutant or overexpression |
How to Study the methyltransferase cap1 activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Structural biology (cryo-EM/X-ray) | Three-dimensional architecture of capping complexes | Understanding co-transcriptional cap1 methylation |
| Kinetic methyltransferase assay | Enzyme velocity and substrate affinity | Characterizing cap methyltransferase activity |
| Bisubstrate inhibitor assay | Inhibition of cap 2'-O-methyltransferases | Antiviral drug discovery |
| RNA-seq | Transcriptome-wide RNA changes | Assessing effects of CMTr1 or DHX15 perturbation |
| Cap-specific sequencing | Cap1 modification status of transcripts | Mapping cap1 sites and efficiency |
| Mouse developmental genetics | Embryonic and fertility phenotypes | Testing essentiality of cap1 methylation |
| Drosophila genetics | Small RNA silencing phenotypes | Linking cap1 to Argonaute 2 pathways |
| Viral replication assays | Viral growth and enzyme function | Testing viral cap1 methyltransferase mutants |
Structural biology of co-transcriptional capping
Structural insights into human co-transcriptional capping reveal how the capping machinery coordinates cap0 formation and cap1 methylation on nascent transcripts. These studies provide a framework for understanding substrate binding and catalysis by GO:0004483 enzymes.
Kinetic and inhibitor assays
Kinetic characterization of human mRNA guanine-N7 methyltransferase establishes quantitative assays for methyl transfer steps in cap formation. Bisubstrate inhibitors that mimic both cap RNA and SAM can be used to probe the catalytic mechanism of cap 2'-O-methyltransferases.
RNA-seq and cap-specific sequencing
RNA-seq and cap-specific sequencing approaches can detect changes in cap1 modification when CMTr1 or DHX15 is perturbed. These methods link GO:0004483 activity to transcriptome-wide RNA fate.
Genetic and developmental models
Mouse genetic models demonstrate that cap-proximal ribose methylation is essential for embryonic development and fertility. Drosophila models connect cap1 methyltransferase activity to small RNA silencing and Argonaute 2 function.
How CRISPR Can Be Used to Study GO:0004483 methyltransferase cap1 activity
Knockout
CRISPR knockout of CMTr1 or DHX15 can be used to test whether cap1 methylation is required for cell viability, RNA stability, and development. Knockout models also help determine which transcripts depend on GO:0004483 activity.
Point Mutation
Catalytic-dead point mutations in cap1 methyltransferase genes can separate enzymatic activity from scaffolding functions. Such point-mutation models are valuable for testing whether the methyl transfer reaction itself is required for a given phenotype.
Knock-in
Tagged knock-in of CMTr1 or DHX15 enables localization and interaction studies in native chromatin and RNA contexts. Knock-in reporters can also be used to monitor cap1 methylation in live cells.
Overexpression
Overexpression of viral cap1 methyltransferases such as chikungunya nsP1 or ASFV EP424R provides systems for antiviral testing and for studying viral replication requirements. Overexpression of human CMTr1 can be used to probe substrate selectivity and structured RNA modification.
How EDITGENE Supports methyltransferase cap1 activity Research
Researchers studying methyltransferase cap1 activity-related genes often need to determine whether a candidate gene is causally involved in cap1 modification, RNA fate, or viral replication. EDITGENE provides CRISPR-engineered cell models and screening services that let you move from correlation to causation with validated knockout, point-mutation, knock-in, and overexpression lines.
Contact EDITGENE today to design your custom CRISPR model for methyltransferase cap1 activity research.
Frequently Asked Questions About methyltransferase cap1 activity
What is methyltransferase cap1 activity?
Methyltransferase cap1 activity (GO:0004483) is the enzyme activity that adds a methyl group to the 2'-O position of the first transcribed nucleotide of mRNA or snRNA, converting cap0 to cap1 using S-adenosyl-L-methionine.
What genes are involved in methyltransferase cap1 activity?
Key genes include CMTr1, which encodes the human cap1 methyltransferase, and DHX15, an RNA helicase that cooperates with CMTr1 on structured 5' termini. Viral genes such as chikungunya nsP1 and ASFV EP424R also encode cap1 methyltransferases.
What is the difference between cap0 and cap1?
Cap0 is the N7-methylguanosine cap added to the 5' end of RNA, while cap1 is formed when the first transcribed nucleotide is additionally 2'-O-methylated by methyltransferase cap1 activity.
Why is cap1 methylation important for development?
Cap-proximal ribose methylation is essential for mammalian embryonic development and fertility, and its loss causes early embryonic lethality in mice.
Do viruses encode cap1 methyltransferases?
Yes. Chikungunya virus nsP1 is a versatile capping and decapping enzyme, and African swine fever virus EP424R functions as a 2'-O-methyltransferase important for viral replication.
How is methyltransferase cap1 activity measured?
It can be measured with kinetic methyltransferase assays, structural biology, bisubstrate inhibitor assays, and cap-specific RNA sequencing.
What is the role of CMTr1 in cap1 methylation?
CMTr1 is the human cap1 2'-O-ribose methyltransferase that converts cap0 to cap1 and cooperates with DHX15 to modify RNAs with structured 5' ends.
Can cap1 methyltransferases be inhibited for antiviral therapy?
Yes. 5'-cap RNA/SAM mimetic conjugates act as bisubstrate inhibitors of viral RNA cap 2'-O-methyltransferases, supporting antiviral development.
What model systems are used to study cap1 methylation?
Common models include mouse developmental genetics, Drosophila small RNA silencing systems, viral replicons, and CRISPR-engineered human cell lines.
What is the GO ID for methyltransferase cap1 activity?
The Gene Ontology ID is GO:0004483, and the term belongs to the molecular_function ontology.
Conclusion
Methyltransferase cap1 activity (GO:0004483) is a conserved enzymatic activity that converts cap0 to cap1 on mRNA and snRNA, using S-adenosyl-L-methionine as the methyl donor. It is essential for mammalian development and fertility, contributes to RNA fate and small RNA silencing, and is encoded by viruses as a replication and immune-evasion factor. Studying this activity with structural, kinetic, genetic, and CRISPR-based approaches continues to reveal its roles in health and disease.
References
- 1. Garg G et al.. 2023. Structural insights into human co-transcriptional capping.. Mol Cell 83(14):2464-2477.e5 PMID: 37369200
- 2. Toczydlowska-Socha D et al.. 2018. Human RNA cap1 methyltransferase CMTr1 cooperates with RNA helicase DHX15 to modify RNAs with highly structured 5' termini.. Philos Trans R Soc Lond B Biol Sci 373(1762) PMID: 30397098
- 3. Lee S et al.. 2020. Roles for Drosophila cap1 2'-O-ribose methyltransferase in the small RNA silencing pathway associated with Argonaute 2.. Insect Biochem Mol Biol 123:103415 PMID: 32504809
- 4. Perveen S et al.. 2024. Kinetic characterization of human mRNA guanine-N7 methyltransferase.. Sci Rep 14(1):4509 PMID: 38402266
- 5. Wang Z et al.. 2026. The EP424R protein of African swine fever virus functions as a 2'-O-methyltransferase and plays an important role in viral replication.. mBio 17(4):e0278625 PMID: 41789918
- 6. Law MCY et al.. 2023. Chikungunya virus nonstructural protein 1 is a versatile RNA capping and decapping enzyme.. J Biol Chem 299(12):105415 PMID: 37918803
- 7. Dohnalkova M et al.. 2023. Essential roles of RNA cap-proximal ribose methylation in mammalian embryonic development and fertility.. Cell Rep 42(7):112786 PMID: 37436893
- 8. Ahmed-Belkacem R et al.. 2024. 5'-cap RNA/SAM mimetic conjugates as bisubstrate inhibitors of viral RNA cap 2'-O-methyltransferases.. Bioorg Chem 143:107035 PMID: 38199140
